Best et al. [272] found elevated glutamate levels, crucial for T cell activation, accompany KRAS/LKB1 co-mutated LUAD, alongside increased glutamine uptake and glutaminase activity in tumor cells. The gene discussed is KRAS; the disease is neoplasm.